Financials
- Market Capitalization 1.79 B
- Employee 377
- Founded 2014
- CEO John Leonard
- Website www.intelliatx.com
- Headquarter Delaware, United States
- FIGI BBG007KC7PB0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.07
市销率
32.42
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2063 | INBX Inhibrx Biosciences, Inc. - Common Stock | 121.74 USD | -3.91% | -0.58% | +48.72% | +51.08% | 1.79 B USD | ||
| 2064 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | -1.76% | -6.18% | +10.23% | -27.23% | 1.79 B USD | ||
| 2074 | SEPN Septerna, Inc. - Common Stock | 37.86 USD | -0.76% | -6.66% | +9.90% | +72.01% | 1.77 B USD | ||
| 2098 | GHRS GH Research PLC - Ordinary Shares | 27.49 USD | +1.89% | -4.65% | -2.41% | +94.14% | 1.71 B USD |